Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Trinity Biotech (TRIB) Debt Ratio (2016 - 2025)

Trinity Biotech's Debt Ratio history spans 15 years, with the latest figure at 0.85 for Q2 2025.

  • On a quarterly basis, Debt Ratio rose 19.35% to 0.85 in Q2 2025 year-over-year; TTM through Jun 2025 was 0.85, a 19.35% increase, with the full-year FY2024 number at 0.72, up 4.86% from a year prior.
  • Debt Ratio hit 0.85 in Q2 2025 for Trinity Biotech, up from 0.72 in the prior quarter.
  • Over the last five years, Debt Ratio for TRIB hit a ceiling of 0.85 in Q2 2025 and a floor of 0.0 in Q4 2021.
  • Historically, Debt Ratio has averaged 0.58 across 5 years, with a median of 0.64 in 2023.
  • Biggest five-year swings in Debt Ratio: surged 184374.75% in 2022 and later dropped 24.9% in 2023.
  • Tracing TRIB's Debt Ratio over 5 years: stood at 0.0 in 2021, then skyrocketed by 184374.75% to 0.48 in 2022, then skyrocketed by 42.14% to 0.68 in 2023, then grew by 4.86% to 0.72 in 2024, then increased by 18.66% to 0.85 in 2025.
  • Business Quant data shows Debt Ratio for TRIB at 0.85 in Q2 2025, 0.72 in Q4 2024, and 0.68 in Q3 2024.